期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

T细胞淋巴瘤的治疗进展 被引量：3

原文传递
导出
摘要 T细胞非霍奇金淋巴瘤（T—NHL）占非霍奇金淋巴瘤（NHL）的10％～15％，在我国约占NHL的25％～35％。除个别亚型外，T—NHL的预后较类似的B细胞淋巴瘤差。由于T—NHL的发病率较低、异质性明显、往往缺乏T细胞克隆免疫表型而使诊断较困难？目前，对于T—NHL尚缺乏随机多中心比较化疗和其他治疗方法的临床试验，其最佳治疗方案还不明确。随着对其研究的深入，逐步认识到T—NHL是一组具有特异性临床和病理特征的疾病类型：2001年WHO根据其临床特点及生物学特性对T—NHL进行新的分类，规范了诊断，为其治疗的研究提供了基础：现就目前几种较常见类型的T—NHL治疗现状及进展作一综述。
作者 袁晓莉 邱录贵
机构地区 中国医学利学院
出处 《中华血液学杂志》 CAS CSCD 北大核心 2006年第10期706-709,共4页 Chinese Journal of Hematology
关键词 T细胞淋巴瘤 治疗方法 非霍奇金淋巴瘤 B细胞淋巴瘤 最佳治疗方案 临床试验 NHL T细胞克隆
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献28

  • 1Tsuchiya T,Ohshima K,Karube K,et al.Th1,Th2,and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma,unspecified:comparison with AILD,ALCL,lymphoblastic lymphoma,and ATLL.Blood,2004,103:236241.
  • 2Ishida T,Inagaki H,Utsunomiya A,et al.CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma,unspecified.Clin Cancer Res,2004,103:236-241.
  • 3Niwa R,Shoji-Hosaka E,Sakurada M,et al.Defucosylated chimeric anti-CCR4 lgGl with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma.Cancer Res,2004,64:2127-2133.
  • 4Sallah S,Wan JY,Nguyen NP.Treatment of refractory T cell malignancies using gemcitabine.Br J Haematol,2001,113:185-187.
  • 5Czuczman MS,Porcu P,Johnson J,et al.CALGB59901:results of a phase Ⅱ study of 506U78 in CTCL and PTCL.Blood,2004,104:2486a.
  • 6Enblad G,Hagberg H,Erlanson MA,et al.A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas.Blood,2004,103:2920-2924.
  • 7Weidmann E,Hess G,Krause SW,et al.Combination chemo-immunotheraphy using alemtuzumab,fludarabine,cyclophosphamide and doxorubicin is an effective first-line regimen in peripheral T-cell lymphoma.Blood,2004,104:2640a.
  • 8Wulf GG,Hasenkamp J,Jung W,et al.Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell nonHodgkin's lymphoma.Bone Marrow Transplant,2005,36:271-273.
  • 9Dang N,Pro B,Hagemeister FB,et al.Interim analysis of a phase Ⅱ study of denileukin diftitox(Ontak) for relapsed/fractory T-cell nonHodgkin lymphoma.Blood,2004,104:722.
  • 10Damaj G,Bouabdallah R,Vey N,et al.Single-agent thalidomide induces response in T-cell lymphoma.Oncogene,2005,24:419-430.

同被引文献30

  • 1茹永新,赵轼轩,刘津华,竺晓凡,秘营昌,肖志坚,邱录贵,王建祥.T-淋巴瘤细胞的超微结构[J].中国实验血液学杂志,2006,14(6):1129-1133. 被引量：4
  • 2宋祖军,王少波,王琦,张永和,尹文,刘健,郭亮.NF—κB的研究进展[J].世界急危重病医学杂志,2007,4(1):1693-1696. 被引量：27
  • 3Kang YH, Park C J, Seo E J, et al. Polymerase chain reaction-based diagnceis of bone marrow involvement in 170 case of non-Hodgkin lymphoma[ J]. Cancer,2002,4(12) :3073-3082.
  • 4Crotty PL,Smith BR,Tallini G. Morpbologic, immunophenotypic and molecular evaluation of bone marrow involvement in non-Hodgkin's lympboma[ J]. Diagn Mol Pathol, 1998,7 (2) :90-95.
  • 5Thiele J,Zirbes T K,Kvasnicka HM ,et al. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma-a practical guideline[J]. J Clin Pathol, 1999,52 (4) :294-300.
  • 6Ferrando A.The role of NOTCH1 signaling in T-ALL[J].Hematology,2009,2009(1):353-361.
  • 7Maddalena P,Ferrando A.Molecular pathogenesis and targetedtherapies for NOTCH1-induced T-cell acute lymphoblastic leukemia[J].Blood Reviews,2011,25(2):83-90.
  • 8Milner LA,Kopan R,Martin DI,et al.A human homologue of thedrosophila developmental gene,notch,is expressed in CD34+hemat-opoietic precursors[J].1994,83(8):2057-2062.
  • 9Ellisen LW,Bird J,West DC,et al.TAN-l,the human homolog of thedrosophila notch gene,is broken by chromosomal translocations in Tlymphoblastic neoplasms[J].Cell,1991,66(4):649-661.
  • 10Stier S,Cheng T,Dombkowski D,et al.Notch1 activation increaseshematopoietic stem cell self-renewal in VIVO and favors lymphoidover myeloid lineage outcome[J].Blood,2002,99(7):2369-2378.

引证文献3

二级引证文献12

中华血液学杂志
2006年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部